Cargando…
A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates
Desensitization protocols comprising plasmapheresis, IVIGs, and rituximab and/or bortezomib have allowed for successful kidney transplantation in some highly HLA-sensitized patients with end-stage renal disease. However, the optimal combination of these therapies and their proper timing remains enti...
Autores principales: | Ide, Kentaro, Tanaka, Yuka, Sasaki, Yu, Tahara, Hiroyuki, Ohira, Masahiro, Ishiyama, Kohei, Tashiro, Hirotaka, Ohdan, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946466/ https://www.ncbi.nlm.nih.gov/pubmed/27500219 http://dx.doi.org/10.1097/TXD.0000000000000526 |
Ejemplares similares
-
Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation
por: Sakai, Hiroshi, et al.
Publicado: (2017) -
Simultaneous Liver-Kidney Transplantation in Patient with a History of Heparin-Induced Thrombocytopenia: A Case Report and Literature Review
por: Taguchi, Kazuhiro, et al.
Publicado: (2019) -
Pancreaticoduodenectomy with preservation of gastric tube blood flow after esophagectomy: Report of a case
por: Okimoto, Sho, et al.
Publicado: (2014) -
B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4(+) T cell responses in highly sensitized transplant recipients
por: Tanaka, Asuka, et al.
Publicado: (2021) -
Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report
por: Honmyo, Naruhiko, et al.
Publicado: (2016)